Nexus AG
XETRA:NXU

Watchlist Manager
Nexus AG Logo
Nexus AG
XETRA:NXU
Watchlist
Price: 69.5 EUR -0.57% Market Closed
Market Cap: 1.2B EUR
Have any thoughts about
Nexus AG?
Write Note

Nexus AG
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexus AG
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Nexus AG
XETRA:NXU
Deferred Income Tax
€14.3m
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
14%
CompuGroup Medical SE & Co KgaA
XETRA:COP
Deferred Income Tax
€94.8m
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
7%
DocCheck AG
XETRA:AJ91
Deferred Income Tax
€161.8k
CAGR 3-Years
-34%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
CHAPTERS Group AG
XETRA:CHG
Deferred Income Tax
€5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nexus AG
Glance View

Market Cap
1.2B EUR
Industry
Health Care

Nexus AG, a prominent figure in the healthcare IT sector, has carved a niche for itself by specializing in software solutions that enhance the operational efficiency and care quality of hospitals and healthcare institutions. Founded with a vision to bridge the gap between innovative technology and healthcare services, Nexus AG crafts integrated software platforms that streamline hospital workflows, from patient admission to billing processes. This not only helps healthcare providers improve service delivery but also allows for smoother regulatory compliance and administrative management. By understanding the unique challenges faced by healthcare professionals, Nexus AG has positioned itself as an indispensable partner to over a thousand hospitals across Europe and beyond. The revenue model of Nexus AG hinges on the strategic deployment of its software solutions, combining upfront licensing fees with ongoing maintenance and support contracts. This ensures a steady stream of recurring revenue, bolstered by consultancy services and tailored modifications that meet client-specific needs. The company continuously invests in research and development to keep its offerings cutting-edge, while also exploring expansion opportunities in adjacent markets and technologies. By fostering long-term relationships with its clients, Nexus AG transforms technological advancement into tangible solutions that provide efficiency and cost savings for the healthcare sector, sustaining its growth and relevance in an ever-evolving market.

NXU Intrinsic Value
60.23 EUR
Overvaluation 13%
Intrinsic Value
Price

See Also

What is Nexus AG's Deferred Income Tax?
Deferred Income Tax
14.3m EUR

Based on the financial report for Sep 30, 2024, Nexus AG's Deferred Income Tax amounts to 14.3m EUR.

What is Nexus AG's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
14%

Over the last year, the Deferred Income Tax growth was -4%. The average annual Deferred Income Tax growth rates for Nexus AG have been 8% over the past three years , 14% over the past five years , and 14% over the past ten years .

Back to Top